Literature DB >> 29187060

Inflammation and atherosclerosis: fulfilling Koch's postulates.

Ishwarlal Jialal1, Naval K Vikram2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29187060      PMCID: PMC5933640          DOI: 10.1177/1753944717744740

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


× No keyword cloud information.
  8 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 2.  Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis.

Authors:  Subodh Verma; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Circulation       Date:  2006-05-02       Impact factor: 29.690

3.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 4.  Anti-inflammatory therapies for cardiovascular disease.

Authors:  Paul M Ridker; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2014-05-26       Impact factor: 29.983

Review 5.  Monocyte-Macrophages and T Cells in Atherosclerosis.

Authors:  Ira Tabas; Andrew H Lichtman
Journal:  Immunity       Date:  2017-10-17       Impact factor: 31.745

Review 6.  Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease.

Authors:  I Jialal; S Devaraj
Journal:  Clin Pharmacol Ther       Date:  2015-06-26       Impact factor: 6.875

Review 7.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

Review 8.  Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.

Authors:  Alberico Luigi Catapano; Angela Pirillo; Giuseppe Danilo Norata
Journal:  Br J Pharmacol       Date:  2017-05-05       Impact factor: 8.739

  8 in total
  3 in total

1.  Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol.

Authors:  Hang Zhao; Linyi Shu; Wenli Huang; Wenzhao Wang; Guangyao Song
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-21       Impact factor: 3.168

2.  Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm.

Authors:  Yen-Kuang Lin; Chi-Tai Yeh; Kuang-Tai Kuo; Iat-Hang Fong; Vijesh Kumar Yadav; Nicholas G Kounis; Patrick Hu; Ming-Yow Hung
Journal:  Oxid Med Cell Longev       Date:  2022-01-19       Impact factor: 6.543

3.  Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

Authors:  Ishwarlal Jialal; Naval Vikram
Journal:  Ther Adv Cardiovasc Dis       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.